首页|SHP2表达变化对四氯化碳诱导的肝纤维化大鼠肝组织中Akt表达的影响

SHP2表达变化对四氯化碳诱导的肝纤维化大鼠肝组织中Akt表达的影响

Effects of SHP2 expression changes on Akt in liver tissues of rats with hepatic fibrosis induced by carbon tetrachloride

扫码查看
目的 探讨含SH2 结构域的蛋白酪氨酸磷酸酶 2(SHP2)过表达及低表达对四氯化碳(CCl4)诱导的肝纤维化大鼠肝组织中蛋白激酶B(Akt)的影响.方法 选取 160 只健康雄性SD大鼠,随机分为对照组、模型组、Ad-GFP组、Ad-SHP2 组和Ad-shRNA/SHP2 组,每组 32 只.采用腹腔注射CCl4 法构建大鼠肝纤维化模型,经大鼠尾静脉分别将表达绿色荧光蛋白(GFP)的空病毒Ad-GFP、表达野生型SHP2 及GFP的腺病毒Ad-SHP2、表达GFP并携带靶向SHP2 的短发夹RNA(shRNA)的腺病毒Ad-shRNA/SHP2 注入大鼠体内.各组分别于造模第 2、4、6、8 周随机选取 8 只大鼠,留取肝组织标本.采用实时荧光定量PCR法检测各组大鼠肝组织中SHP2、Akt的mRNA表达水平,采用蛋白质印迹法检测各组大鼠肝组织中SHP2、Akt及磷酸化Akt(p-Akt)的蛋白表达水平,采用H-E染色法观察各组大鼠肝组织的病理变化,采用Masson三色染色法观察各组大鼠肝组织的胶原沉积情况.结果 靶向SHP2 的shRNA及外源性野生型SHP2 基因成功导入肝纤维化大鼠体内,并使大鼠肝组织中SHP2 呈低表达或过表达.与模型组及Ad-GFP组比较,Ad-SHP2 组大鼠的肝纤维化程度加重,而Ad-shRNA/SHP2 组大鼠的肝纤维化程度则减轻.在同一造模时间点(第 2、4、6、8 周)对各组大鼠肝组织中Akt的mRNA和蛋白表达水平,以及p-Akt蛋白表达水平进行比较,结果显示Ad-GFP组、Ad-SHP2 组、Ad-shRNA/SHP2 组及模型组均显著高于对照组(P均<0.05),而各时间点的Ad-GFP组、Ad-SHP2 组、Ad-shRNA/SHP2 组及模型组的Akt表达水平差异均无统计学意义(P均>0.05);与模型组及Ad-GFP组大鼠肝组织中p-Akt表达水平相比较,Ad-shRNA/SHP2 组在各时间点均显著降低(P均<0.05),Ad-SHP2 组在各时间点均显著升高(P均<0.05),模型组与Ad-GFP组的p-Akt表达水平差异均无统计学意义(P均>0.05).结论 在CCl4 诱导的大鼠肝纤维化病程中,肝组织中SHP2 过表达可通过促进Akt磷酸化增强Akt的活性,而肝组织中SHP2 低表达则可通过抑制Akt磷酸化减弱Akt的活性.
Objective This paper intends to explore the effects of overexpression and low expression of SH2-containing protein tyrosine phosphatase 2(SHP2)on serine-threonine protein kinase(Akt)in liver tissue of carbon tetrachloride(CCl4)induced liver fibrosis rats.Methods One hundred and sixty healthy male SD rats were selected and randomly divided into the control group,the model group,the Ad-GFP group,the Ad-SHP2 group,and the Ad-shRNA/SHP2 group,with 32 rats in each group.A rat liver fibrosis model was constructed by intraperitoneal injection of CCl4.The empty virus Ad-GFP expressing green fluorescent protein(GFP),adenovirus Ad-SHP2 expressing wild-type SHP2 and GFP,and adenovirus Ad-shRNA/SHP2 carrying short hairpin RNA(shRNA)targeting SHP2 expressing GFP were injected into the tail vein of rats.Eight rats were randomly selected from each group at 2nd,4th,6th,and 8th week of modeling,and the liver tissue samples were collected.Real-time fluorescence quantitative PCR(qRT-PCR)was used to detect the mRNA expression levels of SHP2 and Akt in the liver tissues of rats in each group.Western blotting was used to detect the protein expression levels of SHP2,Akt,and phosphorylated Akt(p-Akt)in the liver tissues of rats in each group.H-E staining was used to observe the pathological changes of liver tissue in each group.Masson trichrome staining was used to observe the collagen deposition in liver tissue in each group.Results SHP2-targeted shRNA and wild-type SHP2 gene are successfully introduced into rats with hepatic fibrosis,and the expression of SHP2 in liver tissues of rats is down-regulated and up-regulated.Compared with the model group and the Ad-GFP group,the degree of liver fibrosis in the Ad-SHP2 group aggravated,while the degree of liver fibrosis in the Ad-shRNA/SHP2 group alleviated.The mRNA and protein expression levels of Akt in the liver tissues of rats in each group are compared,as well as the expression levels of p-Akt protein at the same modeling time point(2nd,4th,6th,and 8th week).Those in the Ad-GFP group,the Ad-SHP2 group,the Ad-shRNA/SHP2 group,and the model group are significantly higher than the control group(P<0.05),but the expression of Akt at each time point among the Ad-GFP group,the Ad-SHP2 group,the Ad-shRNA/SHP2 group,and the model group have no significant difference(P>0.05).Compared with the model group and the Ad-GFP group,the expression level of p-Akt protein in the liver tissue of rats in the Ad-shRNA/SHP2 group is significantly reduced(P<0.05),while that in the Ad-SHP2 group is significantly increased(P<0.05).There is no statistically significant difference between the model group and the Ad-GFP group(P>0.05).Conclusion In the course of CCl4 induced liver fibrosis in rats,over expression of SHP2 in liver tissue can increase Akt activity by promoting Akt phosphorylation,while low expression of SHP2 in liver tissue can decline Akt activity by inhibiting Akt phosphorylation.

SH2-containing protein tyrosine phosphatase 2Liver fibrosisProtein kinase B

郝礼森、王薇、季景秀、蒋美钰、苗笑佳、高莹莹、莫艳波、王静

展开 >

063000 河北唐山,华北理工大学附属医院消化内科

061000 沧州市中心医院消化内科

含SH2结构域的蛋白酪氨酸磷酸酶2 肝纤维化 蛋白激酶B

河北省自然科学基金面上项目

H2018209366

2024

国际消化病杂志
上海市医学科学技术情报研究所

国际消化病杂志

CSTPCD
影响因子:0.796
ISSN:1673-534X
年,卷(期):2024.44(1)
  • 19